Trial Profile
A prospective registry study of cetuximab on the occurrence of severe infusion reactions in metastatic colorectal cancer patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- 12 Dec 2015 New trial record